Literature DB >> 12109061

Herpes simplex virus vectors for the nervous system.

C E Lilley1, R H Branston, R S Coffin.   

Abstract

Herpes simplex virus type 1 (HSV1) has a number of properties which could potentially be exploited in the development of vectors for the delivery of genes to the nervous system. These include a natural tropism for neurons, a large viral genome allowing the insertion of multiple exogenous genes, and the ability to establish asymptomatic life-long latent infections. Despite these inherent advantages, the development of HSV vectors successfully exploiting all these properties has been problematical. This has mainly been due to either vector toxicity or an inability to maintain transgene expression in the long term. Recent progress towards overcoming these problems and several applications of the technology are discussed.

Entities:  

Mesh:

Year:  2001        PMID: 12109061     DOI: 10.2174/1566523013348346

Source DB:  PubMed          Journal:  Curr Gene Ther        ISSN: 1566-5232            Impact factor:   4.391


  10 in total

Review 1.  Nonneurotropic adenovirus: a vector for gene transfer to the brain and gene therapy of neurological disorders.

Authors:  Pedro R Lowenstein; Donata Suwelack; Jinwei Hu; Xianpeng Yuan; Maximiliano Jimenez-Dalmaroni; Shyam Goverdhana; Maria G Castro
Journal:  Int Rev Neurobiol       Date:  2003       Impact factor: 3.230

Review 2.  Regulatable gene expression systems for gene therapy applications: progress and future challenges.

Authors:  S Goverdhana; M Puntel; W Xiong; J M Zirger; C Barcia; J F Curtin; E B Soffer; S Mondkar; G D King; J Hu; S A Sciascia; M Candolfi; D S Greengold; P R Lowenstein; M G Castro
Journal:  Mol Ther       Date:  2005-08       Impact factor: 11.454

Review 3.  Regulatable gene expression systems for gene therapy.

Authors:  Nuria Vilaboa; Richard Voellmy
Journal:  Curr Gene Ther       Date:  2006-08       Impact factor: 4.391

4.  Chondroitinase ABC combined with neurotrophin NT-3 secretion and NR2D expression promotes axonal plasticity and functional recovery in rats with lateral hemisection of the spinal cord.

Authors:  Guillermo García-Alías; Hayk A Petrosyan; Lisa Schnell; Philip J Horner; William J Bowers; Lorne M Mendell; James W Fawcett; Victor L Arvanian
Journal:  J Neurosci       Date:  2011-12-07       Impact factor: 6.167

5.  Functional applications of novel Semliki Forest virus vectors are limited by vector toxicity in cultures of primary neurons in vitro and in the substantia nigra in vivo.

Authors:  Paul Lingor; Ulrike Schöll; Mathias Bähr; Sebastian Kügler
Journal:  Exp Brain Res       Date:  2004-10-20       Impact factor: 1.972

Review 6.  Transneuronal circuit tracing with neurotropic viruses.

Authors:  Edward M Callaway
Journal:  Curr Opin Neurobiol       Date:  2009-04-06       Impact factor: 6.627

7.  Fabrication and Optimization of Linear PEI-Modified Crystal Nanocellulose as an Efficient Non-Viral Vector for In-Vitro Gene Delivery.

Authors:  Haghighat Vakilian; Eduardo Andres Rojas; Lida Habibi Rezaei; Mehrdad Behmanesh
Journal:  Rep Biochem Mol Biol       Date:  2020-10

8.  Genetic approaches to reveal the connectivity of adult-born neurons.

Authors:  Benjamin R Arenkiel
Journal:  Front Neurosci       Date:  2011-04-05       Impact factor: 4.677

9.  Gene therapy for Parkinson's disease.

Authors:  Rachel Denyer; Michael R Douglas
Journal:  Parkinsons Dis       Date:  2012-03-25

10.  Genetic strategies to investigate neuronal circuit properties using stem cell-derived neurons.

Authors:  Isabella Garcia; Cynthia Kim; Benjamin R Arenkiel
Journal:  Front Cell Neurosci       Date:  2012-12-18       Impact factor: 5.505

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.